BridgeMD
New treatment option for Major Abdominal Surgeries
Official title Intraoperative Multimodal Monitoring as a Means in Reducing the Duration of Mechanical Ventilation in High-Risk Patients Undergoing Major Abdominal Procedures - A Pilot Study
ClinicalTrials.gov ID: NCT07339449
What this study is testing
- What it's testing
- This study will include patients aged 50 and older scheduled for elective abdominal oncologic surgery, classified as ASA II and III due to increased anaesthetic and surgical risk. Gender will not be a stratification factor.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- aged 50 years or older
- scheduled for elective major abdominal surgery, specifically those classified as ASA II and ASA III
You likely can't join if
- patient refusal;
- memory impairment (psychosis);
- known or suspected electroencephalo-graphic abnormalities (such as epilepsy or previous brain surgery);
- chronic use of psy-choactive medication;
- urgent or emergent procedures;
- body mass index (BMI) below 18 kg/m2 or above 35 kg/m2;
See the full eligibility criteria
- aged 50 years or older
- scheduled for elective major abdominal surgery, specifically those classified as ASA II and ASA III
- patient refusal;
- memory impairment (psychosis);
- known or suspected electroencephalo-graphic abnormalities (such as epilepsy or previous brain surgery);
- chronic use of psy-choactive medication;
- urgent or emergent procedures;
- body mass index (BMI) below 18 kg/m2 or above 35 kg/m2;
- persistent arrhythmias including atrial fibrillation and undulation;
- documented NYHA class III-IV heart failure or a preoperative left ventricular ejection fraction below 30%;
- valvular disease involving aortic and/or mitral stenosis or regurgita-tion;
- liver diseases such as decompensated cirrhosis and coagulopathies;
- anticipated operation duration exceeding six hours.
The study team makes the final eligibility decision.
Where it's taking place
- Zagreb, Croatia, Croatia
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zagreb, Croatia, Croatia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.